186 related articles for article (PubMed ID: 37082943)
1. CX3CL1 induces cell migration and invasion through ICAM-1 expression in oral squamous cell carcinoma cells.
Wu CY; Peng PW; Renn TY; Lee CJ; Chang TM; Wei AI; Liu JF
J Cell Mol Med; 2023 Jun; 27(11):1509-1522. PubMed ID: 37082943
[TBL] [Abstract][Full Text] [Related]
2. Syk/JNK/AP-1 signaling pathway mediates interleukin-6-promoted cell migration in oral squamous cell carcinoma.
Chuang JY; Huang YL; Yen WL; Chiang IP; Tsai MH; Tang CH
Int J Mol Sci; 2014 Jan; 15(1):545-59. PubMed ID: 24398980
[TBL] [Abstract][Full Text] [Related]
3. Vertebral-specific activation of the CX3CL1/ICAM-1 signaling network mediates non-small-cell lung cancer spinal metastasis by engaging tumor cell-vertebral bone marrow endothelial cell interactions.
Wang K; Jiang L; Hu A; Sun C; Zhou L; Huang Y; Chen Q; Dong J; Zhou X; Zhang F
Theranostics; 2021; 11(10):4770-4789. PubMed ID: 33754027
[No Abstract] [Full Text] [Related]
4. ADAM17-regulated CX3CL1 expression produced by bone marrow endothelial cells promotes spinal metastasis from hepatocellular carcinoma.
Sun C; Hu A; Wang S; Tian B; Jiang L; Liang Y; Wang H; Dong J
Int J Oncol; 2020 Jul; 57(1):249-263. PubMed ID: 32319605
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-29b regulates migration in oral squamous cell carcinoma and its clinical significance.
Yang CN; Deng YT; Tang JY; Cheng SJ; Chen ST; Li YJ; Wu TS; Yang MH; Lin BR; Kuo MY; Ko JY; Chang CC
Oral Oncol; 2015 Feb; 51(2):170-7. PubMed ID: 25435433
[TBL] [Abstract][Full Text] [Related]
6. CX3CL1 in the red bone marrow promotes renal cell carcinoma to metastasize to the spine by involving the Src-related pathway.
Hu AN; Chen FC; Wang KT; Wang ZQ; Liang Y; Dong J
Neoplasma; 2022 May; 69(3):670-679. PubMed ID: 35330998
[TBL] [Abstract][Full Text] [Related]
7. CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway.
Liu P; Liang Y; Jiang L; Wang H; Wang S; Dong J
Int J Oncol; 2018 Oct; 53(4):1544-1556. PubMed ID: 30066854
[TBL] [Abstract][Full Text] [Related]
8. Double-faced CX3CL1 enhances lymphangiogenesis-dependent metastasis in an aggressive subclone of oral squamous cell carcinoma.
Eain HS; Kawai H; Nakayama M; Oo MW; Ohara T; Fukuhara Y; Takabatake K; Shan Q; Soe Y; Ono K; Nakano K; Mizukawa N; Iida S; Nagatsuka H
JCI Insight; 2024 May; 9(10):. PubMed ID: 38775151
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis signal-regulating kinase 1 is involved in WISP-1-promoted cell motility in human oral squamous cell carcinoma cells.
Chuang JY; Chang AC; Chiang IP; Tsai MH; Tang CH
PLoS One; 2013; 8(10):e78022. PubMed ID: 24205072
[TBL] [Abstract][Full Text] [Related]
10. CX3CL1 promotes lung cancer cell migration and invasion via the Src/focal adhesion kinase signaling pathway.
Liu W; Liang Y; Chan Q; Jiang L; Dong J
Oncol Rep; 2019 Mar; 41(3):1911-1917. PubMed ID: 30628679
[TBL] [Abstract][Full Text] [Related]
11. Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma.
Shan Q; Takabatake K; Omori H; Kawai H; Oo MW; Nakano K; Ibaragi S; Sasaki A; Nagatsuka H
Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34368860
[TBL] [Abstract][Full Text] [Related]
12. BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
Shan F; Shen S; Wang X; Chen G
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36929425
[TBL] [Abstract][Full Text] [Related]
13. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
Prgomet Z; Axelsson L; Lindberg P; Andersson T
J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
[TBL] [Abstract][Full Text] [Related]
14. The miR-561-5p/CX
Chen EB; Zhou ZJ; Xiao K; Zhu GQ; Yang Y; Wang B; Zhou SL; Chen Q; Yin D; Wang Z; Shi YH; Gao DM; Chen J; Zhao Y; Wu WZ; Fan J; Zhou J; Dai Z
Theranostics; 2019; 9(16):4779-4794. PubMed ID: 31367257
[TBL] [Abstract][Full Text] [Related]
15. Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cells.
Lai KC; Liu CJ; Chang KW; Lee TC
Oncogene; 2013 Aug; 32(32):3686-97. PubMed ID: 22986528
[TBL] [Abstract][Full Text] [Related]
16. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
17. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
[TBL] [Abstract][Full Text] [Related]
18. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]